Pages that link to "Q42274823"
Jump to navigation
Jump to search
The following pages link to Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine (Q42274823):
Displaying 50 items.
- The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms (Q24653930) (← links)
- Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine (Q28509847) (← links)
- Antipsychotic-like effects of a neurotensin receptor type 1 agonist. (Q30356261) (← links)
- Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia (Q30375799) (← links)
- Animal models of tic disorders: a translational perspective (Q30395243) (← links)
- Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon? (Q30415567) (← links)
- The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+‐induced apoptosis (Q33187053) (← links)
- Long-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approach (Q33607534) (← links)
- Adult rats treated with risperidone during development are hyperactive. (Q33697364) (← links)
- Discriminative stimulus properties of antipsychotics (Q33748875) (← links)
- 5-HT6 Receptor Ligands and their Antipsychotic Potential (Q34165258) (← links)
- Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice (Q34225457) (← links)
- Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats (Q34236634) (← links)
- Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist (Q34405306) (← links)
- The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behaviour in Cebus apella monkeys (Q34407060) (← links)
- SB-258741: a 5-HT7 receptor antagonist of potential clinical interest. (Q34692022) (← links)
- Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects. (Q35162561) (← links)
- Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia (Q35197029) (← links)
- Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions. (Q35742020) (← links)
- Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats (Q35990486) (← links)
- The behavioral actions of lithium in rodent models: leads to develop novel therapeutics (Q36293345) (← links)
- Asenapine effects in animal models of psychosis and cognitive function (Q37370296) (← links)
- Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity (Q37396860) (← links)
- Dopamine modulates effort-based decision making in rats (Q37468632) (← links)
- The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment (Q37826638) (← links)
- Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death. (Q39552320) (← links)
- Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activation. (Q40339992) (← links)
- Delayed yet persistent effects of daily risperidone on activity in developing rats (Q41817162) (← links)
- Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway (Q41901747) (← links)
- Serotonergic basis of antipsychotic drug effects in schizophrenia. (Q42537934) (← links)
- Olanzapine attenuates the reinforcing effects of cocaine (Q42543968) (← links)
- The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations (Q42546433) (← links)
- Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion (Q42547819) (← links)
- Models for assessing antipsychotics: antagonism of amphetamine-induced hyperactivity and stereotypies in mice (Q42726395) (← links)
- Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole (Q42961384) (← links)
- Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants (Q43286008) (← links)
- Lack of specific effects of selective D(1) and D(2) dopamine antagonists vs. risperidone on morphine-induced hyperactivity (Q43503756) (← links)
- Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity (Q43656929) (← links)
- Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia (Q43913079) (← links)
- Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia (Q43913085) (← links)
- Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine (Q44026211) (← links)
- Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents (Q44259205) (← links)
- LABORAS™: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour (Q44635393) (← links)
- Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient (Q45753049) (← links)
- Validation of a motor activity system by a robotically controlled vehicle and using standard reference compounds (Q46591914) (← links)
- Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion (Q46798764) (← links)
- Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats. (Q46808081) (← links)
- The "induced hyperactivity" test for the de-risking of potential off-target activity of antihypertensive drugs (Q47428145) (← links)
- Differential changes in induced seizures after hippocampal treatment of rats with an antisense oligodeoxynucleotide to the GABA(A) receptor gamma2 subunit (Q48492210) (← links)
- No Major Differences in Locomotor Responses to Dexamphetamine in High and Low Responders to Novelty: A Study in Wistar Rats (Q48741863) (← links)